Sarcoma Foundation of America, Inc.

03/23/2026

Thank you to Chikage Windler and CBS Austin for joining us at our race this past Saturday! Your support helps raise awareness for sarcoma. We are grateful to have you standing with patients, families, and everyone affected by sarcoma.

Read the article:

AUSTIN, Texas -

03/23/2026

You do not have to face sarcoma alone.

Through Sarcoma Match, our free peer-to-peer support program with Imerman Angels, patients, survivors, and care partners can be matched with a mentor who understands the sarcoma journey firsthand. Through this partnership, we are working to reduce isolation and foster meaningful connections through shared experiences so that every person impacted by sarcoma has someone to turn to.

Find connection and guidance by signing up today to be matched with a mentor.

More information: curesarcoma.org/support-resources/sarcoma-match/

03/20/2026

Registration for the Marine Corps Marathon is open! Join the RTCS Marathon Team at the on October 25 in Arlington, VA!

SFA is a proud charity partner of the 2026 Marine Corps Marathon. Run with us to raise awareness and funds for research. Every step supports the Sarcoma Foundation of America's mission to .

If you are interested in joining our race team, find more information here: https://buff.ly/Q1fwPfZ

Can’t run? Share this with friends or family who might want to take on the challenge!

No Federal or Marine Corps Endorsement Implied.

03/19/2026

Join our Advocacy Weekend Information Session next week on 3/24 to learn more about Advocacy Weekend in Washington, D.C. this July.

During this session, you’ll hear what to expect during the 3-day event and how advocating, sharing your story, and connecting with lawmakers can help bring greater awareness, funding, and progress for sarcoma research and patient care.

Register: https://buff.ly/18iqJvP

03/18/2026

Registration for RTCS Austin is still open! Happening this weekend!

RTCS Austin is just one week away! Join us as we bring together hundreds of members of the community who have been impacted by sarcoma. We celebrate, honor, and remember those affected by this rare disease.

Thanks to your support and hard work we are over halfway to our $45,000 goal! Thank you!

Register or show your support here: curesarcoma.org/austin

03/18/2026

Soft tissue sarcoma (STS) is a rare and challenging cancer, and finding effective treatments has been an ongoing area of research. A new clinical trial published in Clinical Cancer Research tested a combination of doxorubicin and durvalumab in patients with advanced STS:

What they found:
- 31.7% of patients had tumors shrink (response rate)
- 82.9% achieved disease control
- 7.6 month median progression-free survival
- 23.8 month median overall survival

The researchers also identified biological markers in the tumors that may help predict which patients are most likely to benefit. This kind of research moves us closer to matching the right therapy to the right patient.

While further studies are needed, these results are a meaningful step forward for patients and families affected by this disease.

03/17/2026

Rare shouldn’t mean overlooked.

20% sarcomas are ultra-rare, meaning they have an incidence of 1 per 1,000,000 or less. For patients facing these diagnoses, rarity often means fewer research dollars, limited treatment options, and too few answers.

Supporting sarcoma research helps ensure that every patient, no matter how rare their diagnosis, receives the attention, care, and scientific focus they deserve.

03/16/2026

Part 2 of our ctDNA in Sarcomas Live with the Experts series is happening next week! Join Dr. David Shulman (Dana-Farber Cancer Institute) and Dr. Edwin Choy (Massachusetts General Hospital) as they share deeper insights into how ctDNA is being used in oncology and what it could mean for sarcoma research and care.

We’ll also hear from patient advocate Zach Ward, who will share his experience navigating clear cell sarcoma and ctDNA testing conversations, offering a real-world perspective on the questions and decisions families face.

During this session, we’ll cover a quick refresher on ctDNA basics, new insights since Part 1, unanswered audience questions, and a discussion on ctDNA’s current and future role in sarcoma research and clinical care—plus a live Q&A.

If you want to catch up on the previous ctDNA Live with the Experts, you can find the first part on our YouTube channel.

Register: https://us06web.zoom.us/webinar/register/WN_BVGsNx-0SgOUlDObtw041A #/registration

03/13/2026

National Adolescent and Young Adult (AYA) Week is April 5–11. Your story has the power to inspire, connect, and bring hope to someone else facing sarcoma.

We invite you to share your journey and be featured on the Patient Stories page of our website. By telling your story, you help others feel less alone and remind our community that there is understanding, support, and a community standing beside them.

Submit your story: https://curesarcoma.org/support-resources/sarcoma-patient-stories/share-your-story/

03/12/2026

A huge thank you to our Austin RTCS sponsors!

Your partnership helps bring our community together and fuels critical research, advocacy, and support for patients and families facing sarcoma. We are grateful for your commitment to the sarcoma community and for helping make this event possible.

03/12/2026

On this episode, we’re joined by Simone Cheatham, a member of the Race to Cure Sarcoma Chicago Committee. Simone became actively involved after her late father, Hardin, was diagnosed with sarcoma after already being diagnosed with breast cancer.

Simone shares what it was like to support her father as a care partner alongside her mother while navigating a rare cancer diagnosis. Shortly after his diagnosis, Simone herself was diagnosed with Hodgkin’s lymphoma. She reflects on the stark differences between her own treatment options and those available to her father, and why advocacy and research in the sarcoma space are so critical.

Listen wherever you get podcasts!

03/11/2026

Join us for Part 2 of our "Live with the Experts" series on circulating tumor DNA (ctDNA) in sarcoma on Wednesday, March 25, 2026, at 1:00 PM ET. Building on our first session, An Introduction to ctDNA in Sarcoma, this webinar takes the conversation a step further and highlights new research, practical considerations, and the real-world questions patients and clinicians are navigating today.

Register: https://us06web.zoom.us/webinar/register/WN_BVGsNx-0SgOUlDObtw041A #/registration